Blood Culture Detection, ID and Susceptibility Testing

The Department of Veterans Affairs, James J. Peters Veterans Affairs Medical Center, intends to award a sole-source, firm fixed-price contract to Biomerieux Inc., in accordance with FAR Subpart 6.302-2. This requirement is a logical follow-on contract from the Blood Culture Detection, Identification, and Antimicrobial Susceptibility Testing to ensure continuity of patient care at the VA Medical Center locations listed below.

The contract will cover consumables and supplies needed to produce cost-per-kit (CPK) and for the continued usage of contractor-owned equipment currently on-site: * James J. Peters (Bronx) VAMC * East Orange VAMC (NJ) * Margaret Cochran Corbin VA Campus * Northport VAMC VA personnel utilize the equipment and consumables to perform in-house testing for Blood Culture Detection, Identification, and Antimicrobial Susceptibility Testing CPK services.

The NAICS code is 334516, with a small business standard of 1,000 employees. The current contract with Biomerieux Inc. will expire on March 31, 2026. The VA Medical Centers listed above require a follow-on contract from the Bacterial ID & Susceptibility Long Term Agreement to ensure continuity of patient care. This contract is necessary to avoid unnecessary interruption to the medical facilities. This notice of intent is not a request for competitive proposals, and no solicitation will be made available.

Any responses received no later than COB February 12, 2026, will be considered for the purpose of determining sources for future procurements. The Government will not pay for information submitted. Any information submitted in response to this notice of intent is strictly voluntary. This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement.